Other

Net Change in Cash and Restricted Cash

West Pharmaceutical Services Net Change in Cash and Restricted Cash decreased by 327.2% to -$269.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 235.7%, from -$80.40M to -$269.90M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026

How to read this metric

A positive change indicates net cash generation, while a negative change indicates net cash consumption.

Detailed definition

This represents the total net increase or decrease in the company's cash, cash equivalents, and restricted cash balances...

Peer comparison

A standard liquidity metric found in the statement of cash flows for all public companies.

Metric ID: cvx_net_change_in_cash_and_restricted_cash

Historical Data

11 periods
 Q3 '21Q1 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$111.80M-$94.90M-$8.00M-$90.00M$102.30M-$252.10M-$155.60M-$80.40M$105.50M$118.80M-$269.90M
QoQ Change-184.9%+91.6%<-999%+213.7%-346.4%+38.3%+48.3%+231.2%+12.6%-327.2%
YoY Change+91.6%<-999%-72.9%+68.1%+167.8%-235.7%
Range-$269.90M$118.80M
CAGR+42.3%
Avg YoY Growth-505.4%
Median YoY Growth-2.4%

Net Change in Cash and Restricted Cash at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's net change in cash and restricted cash?
West Pharmaceutical Services (WST) reported net change in cash and restricted cash of -$269.90M in Q1 2026.
How has West Pharmaceutical Services's net change in cash and restricted cash changed year-over-year?
West Pharmaceutical Services's net change in cash and restricted cash decreased by 235.7% year-over-year, from -$80.40M to -$269.90M.
What does net change in cash and restricted cash mean?
The total net movement in the company's available cash and restricted cash reserves during the period.